These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 33164547)
21. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy. Shyng SL; Ferrigni T; Shepard JB; Nestorowicz A; Glaser B; Permutt MA; Nichols CG Diabetes; 1998 Jul; 47(7):1145-51. PubMed ID: 9648840 [TBL] [Abstract][Full Text] [Related]
22. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism. Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916 [TBL] [Abstract][Full Text] [Related]
23. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide. Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850 [TBL] [Abstract][Full Text] [Related]
30. Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives. Hansen JB Curr Med Chem; 2006; 13(4):361-76. PubMed ID: 16475928 [TBL] [Abstract][Full Text] [Related]
31. Mechanisms of the glycaemic effects of sulfonylureas. Ashcroft FM Horm Metab Res; 1996 Sep; 28(9):456-63. PubMed ID: 8911983 [TBL] [Abstract][Full Text] [Related]
32. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands. Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126 [TBL] [Abstract][Full Text] [Related]
33. Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs. Horie M; Ishida-Takahashi A; Ai T; Nishimoto T; Tsuura Y; Ishida H; Seino Y; Sasayama S Cardiovasc Res; 1997 Apr; 34(1):69-72. PubMed ID: 9217874 [TBL] [Abstract][Full Text] [Related]
34. Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice. Seino S; Iwanaga T; Nagashima K; Miki T Diabetes; 2000 Mar; 49(3):311-8. PubMed ID: 10868950 [TBL] [Abstract][Full Text] [Related]
35. Treating diabetes today: a matter of selectivity of sulphonylureas. Seino S; Takahashi H; Takahashi T; Shibasaki T Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():9-13. PubMed ID: 22118705 [TBL] [Abstract][Full Text] [Related]
36. Spacial models of malfunctioned protein complexes help to elucidate signal transduction critical for insulin release. Walczewska-Szewc K; Nowak W Biosystems; 2019 Mar; 177():48-55. PubMed ID: 30395892 [TBL] [Abstract][Full Text] [Related]
37. Kaiyuqingre formula improves insulin secretion via regulating uncoupling protein-2 and KATP channel. Tong XL; Song J; Zhao LH; Ji HY Chin Med J (Engl); 2011 Sep; 124(17):2746-50. PubMed ID: 22040435 [TBL] [Abstract][Full Text] [Related]
38. [Permanent neonatal diabetes with known genetic background: oral drugs in treatment of childhood diabetes]. Gach A; Gadzicka A; Młynarski W Pediatr Endocrinol Diabetes Metab; 2008; 14(1):45-9. PubMed ID: 18577347 [TBL] [Abstract][Full Text] [Related]
39. Berberine is an insulin secretagogue targeting the KCNH6 potassium channel. Zhao MM; Lu J; Li S; Wang H; Cao X; Li Q; Shi TT; Matsunaga K; Chen C; Huang H; Izumi T; Yang JK Nat Commun; 2021 Sep; 12(1):5616. PubMed ID: 34556670 [TBL] [Abstract][Full Text] [Related]